CELL LINE DEVELOPMENT
SECURE YOUR MARKET SUPPLY WITH PROTEINS. START WITH A GOOD CELL LINE AND CULTURE MEDIUM.
WE DEVELOP A PLATFORM TECHNOLOGY CONSIDERING ALL MODULES OF UPSTREAM PROCESS. WE DELIVER CELL LINES TOGETHER WITH CULTURE MEDIA AS PRODUCT.
We are convinced of having an integral approach in everything we do. Punctual solutions seldom bring sustainable value to the clients. We develop a platform technology for manufacturing of recombinant proteins and vaccines with cell culture. Our product is our platform technology.
Using our platform we develop production cell lines for our clients in a short time. Our culture media and generic production process are previously optimized for our cells so that there is no repetitive development of culture media or bioreactor process is necessary. Our production processes are characterized through high product concentration. We focus on fed-batch production processes of cell cultures. The process productivities vary between 3 and 5 g/L in a typical 12-day process for antibodies. Robust manufacturing process is a prerequisite of health authorities. Our cells, media and processes reduce the process failure. We found that process risks are mostly associated to human interpretation of data and human intervention into the process. We design manufacturing processes in a way that it runs by itself with limited daily interactions by humans. Especially clients who don’t have very experienced employees appreciate our automatic processes.